Accelerating Gene Editing Therapies for Rare, Neurological Conditions

Steve Murray, associate professor at The Jackson Laboratory, discusses the promise of gene-editing therapies, the work the lab is leading grant under a $22.8 million NIH grant to develop four gene-editing therapies for rare neurological conditions, and why the work could have broad implications for similar conditions.